The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Labeur, M. S.
Right arrow Articles by Grabbe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Labeur, M. S.
Right arrow Articles by Grabbe, S.
The Journal of Immunology, 1999, 162: 168-175.
Copyright © 1999 by The American Association of Immunologists

Generation of Tumor Immunity by Bone Marrow-Derived Dendritic Cells Correlates with Dendritic Cell Maturation Stage1

Marta S. Labeur, Berthold Roters, Birgit Pers, Annette Mehling, Thomas A. Luger, Thomas Schwarz and Stephan Grabbe2

Ludwig Boltzmann Institute for Cell Biology and Immunobiology of the Skin, Department of Dermatology, University of Munster, Munster, Germany

Bone marrow-derived dendritic cells (BmDC) are potent APC and can promote antitumor immunity in mice when pulsed with tumor Ag. This study aimed to define the culture conditions and maturation stages of BmDC that enable them to optimally function as APC in vivo. BmDC cultured under various conditions (granulocyte-macrophage CSF (GM-CSF) or GM-CSF plus IL-4 alone or in combination with Flt3 ligand, TNF-{alpha}, LPS, or CD40 ligand (CD40L)) were analyzed morphologically, phenotypically, and functionally and were tested for their ability to promote prophylactic and/or therapeutic antitumor immunity. Each of the culture conditions generated typical BmDC. Whereas cells cultured in GM-CSF alone were functionally immature, cells incubated with CD40L or LPS were mature BmDC, as evident by morphology, capacity to internalize Ag, migration into regional lymph nodes, IL-12 secretion, and alloantigen or peptide Ag presentation in vitro. The remaining cultures exhibited intermediate dendritic cell maturation. The in vivo Ag-presenting capacity of BmDC was compared with respect to induction of both protective tumor immunity and immunotherapy of established tumors, using the poorly immunogenic squamous cell carcinoma, KLN205. In correspondence to their maturation stage, BmDC cultured in the presence of CD40L exhibited the most potent immunostimulatory effects. In general, although not entirely, the capacity of BmDC to induce an antitumor immune response in vivo correlated to their degree of maturation. The present data support the clinical use of mature, rather than immature, tumor Ag-pulsed dendritic cells as cancer vaccines and identifies CD40L as a potent stimulus to enhance their in vivo Ag-presenting capacity.




This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Y. Gerner, K. A. Casey, and M. F. Mescher
Defective MHC Class II Presentation by Dendritic Cells Limits CD4 T Cell Help for Antitumor CD8 T Cell Responses
J. Immunol., July 1, 2008; 181(1): 155 - 164.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-J. Kim, S.-Y. Hwang, J.-S. Hwang, J.-W. Lee, E.-S. Oh, and I.-O. Han
C6 Glioma Cell Insoluble Matrix Components Enhance Interferon-{gamma}-stimulated Inducible Nitric-oxide Synthase/Nitric Oxide Production in BV2 Microglial Cells
J. Biol. Chem., February 1, 2008; 283(5): 2526 - 2533.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
O. Fainaru, A. Adini, O. Benny, I. Adini, S. Short, L. Bazinet, K. Nakai, E. Pravda, M. D. Hornstein, R. J. D'Amato, et al.
Dendritic cells support angiogenesis and promote lesion growth in a murine model of endometriosis
FASEB J, February 1, 2008; 22(2): 522 - 529.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
U. Sriram, C. Biswas, E. M. Behrens, J.-A. Dinnall, D. K. Shivers, M. Monestier, Y. Argon, and S. Gallucci
IL-4 Suppresses Dendritic Cell Response to Type I Interferons
J. Immunol., November 15, 2007; 179(10): 6446 - 6455.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Reichardt, B. Dornbach, S. Rong, S. Beissert, F. Gueler, K. Loser, and M. Gunzer
Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse
Blood, September 1, 2007; 110(5): 1519 - 1529.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. P. Phadke, G. Akangire, S. J. Park, S. A. Lira, and B. Mehrad
The Role of CC Chemokine Receptor 6 in Host Defense in a Model of Invasive Pulmonary Aspergillosis
Am. J. Respir. Crit. Care Med., June 1, 2007; 175(11): 1165 - 1172.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Varga, S. Balkow, M. K. Wild, A. Stadtbaeumer, M. Krummen, T. Rothoeft, T. Higuchi, S. Beissert, K. Wethmar, K. Scharffetter-Kochanek, et al.
Active MAC-1 (CD11b/CD18) on DCs inhibits full T-cell activation
Blood, January 15, 2007; 109(2): 661 - 669.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Udagawa, C. Kudo-Saito, G. Hasegawa, K. Yano, A. Yamamoto, M. Yaguchi, M. Toda, I. Azuma, T. Iwai, and Y. Kawakami
Enhancement of Immunologic Tumor Regression by Intratumoral Administration of Dendritic Cells in Combination with Cryoablative Tumor Pretreatment and Bacillus Calmette-Guerin Cell Wall Skeleton Stimulation
Clin. Cancer Res., December 15, 2006; 12(24): 7465 - 7475.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.-G. de Goer de Herve, D. Durali, T.-A. Tran, G. Maigne, F. Simonetta, P. Leclerc, J.-F. Delfraissy, and Y. Taoufik
Differential effect of agonistic anti-CD40 on human mature and immature dendritic cells: the Janus face of anti-CD40
Blood, October 15, 2005; 106(8): 2806 - 2814.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. K. Kang, H.-Y. Lee, M.-K. Kim, K. S. Park, Y. M. Park, J.-Y. Kwak, and Y.-S. Bae
The Synthetic Peptide Trp-Lys-Tyr-Met-Val-D-Met Inhibits Human Monocyte-Derived Dendritic Cell Maturation via Formyl Peptide Receptor and Formyl Peptide Receptor-Like 2
J. Immunol., July 15, 2005; 175(2): 685 - 692.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Yamanaka, J. Homma, N. Yajima, N. Tsuchiya, M. Sano, T. Kobayashi, S. Yoshida, T. Abe, M. Narita, M. Takahashi, et al.
Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial
Clin. Cancer Res., June 1, 2005; 11(11): 4160 - 4167.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Menges, T. Baumeister, S. Rossner, P. Stoitzner, N. Romani, A. Gessner, and M. B. Lutz
IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity
J. Leukoc. Biol., April 1, 2005; 77(4): 535 - 543.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Ito, C. Nishiyama, M. Nishiyama, H. Matsuda, K. Maeda, Y. Akizawa, R. Tsuboi, K. Okumura, and H. Ogawa
Mast Cells Acquire Monocyte-Specific Gene Expression and Monocyte-Like Morphology by Overproduction of PU.1
J. Immunol., January 1, 2005; 174(1): 376 - 383.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. J. D. van Mierlo, Z. F. H. M. Boonman, H. M. H. Dumortier, A. Th. den Boer, M. F. Fransen, J. Nouta, E. I. H. van der Voort, R. Offringa, R. E. M. Toes, and C. J. M. Melief
Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication
J. Immunol., December 1, 2004; 173(11): 6753 - 6759.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Stumbles, R. Himbeck, J. A. Frelinger, E. J. Collins, R. A. Lake, and B. W. S. Robinson
Cutting Edge: Tumor-Specific CTL Are Constitutively Cross-Armed in Draining Lymph Nodes and Transiently Disseminate to Mediate Tumor Regression following Systemic CD40 Activation
J. Immunol., November 15, 2004; 173(10): 5923 - 5928.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Gunzer, C. Weishaupt, A. Hillmer, Y. Basoglu, P. Friedl, K. E. Dittmar, W. Kolanus, G. Varga, and S. Grabbe
A spectrum of biophysical interaction modes between T cells and different antigen-presenting cells during priming in 3-D collagen and in vivo
Blood, November 1, 2004; 104(9): 2801 - 2809.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
T. Katakai, T. Hara, M. Sugai, H. Gonda, and A. Shimizu
Lymph Node Fibroblastic Reticular Cells Construct the Stromal Reticulum via Contact with Lymphocytes
J. Exp. Med., September 20, 2004; 200(6): 783 - 795.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
T. Katakai, T. Hara, J.-H. Lee, H. Gonda, M. Sugai, and A. Shimizu
A novel reticular stromal structure in lymph node cortex: an immuno-platform for interactions among dendritic cells, T cells and B cells
Int. Immunol., August 1, 2004; 16(8): 1133 - 1142.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
S.-i. Fujii, K. Liu, C. Smith, A. J. Bonito, and R. M. Steinman
The Linkage of Innate to Adaptive Immunity via Maturing Dendritic Cells In Vivo Requires CD40 Ligation in Addition to Antigen Presentation and CD80/86 Costimulation
J. Exp. Med., June 21, 2004; 199(12): 1607 - 1618.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. M. Cisco, Z. Abdel-Wahab, J. Dannull, S. Nair, D. S. Tyler, E. Gilboa, J. Vieweg, Y. Daaka, and S. K. Pruitt
Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 4
J. Immunol., June 1, 2004; 172(11): 7162 - 7168.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Terme, E. Tomasello, K. Maruyama, F. Crepineau, N. Chaput, C. Flament, J.-P. Marolleau, E. Angevin, E. F. Wagner, B. Salomon, et al.
IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules
J. Immunol., May 15, 2004; 172(10): 5957 - 5966.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. R. Ramirez-Pineda, A. Frohlich, C. Berberich, and H. Moll
Dendritic Cells (DC) Activated by CpG DNA Ex Vivo Are Potent Inducers of Host Resistance to an Intracellular Pathogen That Is Independent of IL-12 Derived from the Immunizing DC
J. Immunol., May 15, 2004; 172(10): 6281 - 6289.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Nair, C. McLaughlin, A. Weizer, Z. Su, D. Boczkowski, J. Dannull, J. Vieweg, and E. Gilboa
Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation
J. Immunol., December 1, 2003; 171(11): 6275 - 6282.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Xu, G. K. Koski, M. Faries, I. Bedrosian, R. Mick, M. Maeurer, M. A. Cheever, P. A. Cohen, and B. J. Czerniecki
Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependent Mechanism
J. Immunol., September 1, 2003; 171(5): 2251 - 2261.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. L. Doxsee, T. R. Riter, M. J. Reiter, S. J. Gibson, J. P. Vasilakos, and R. M. Kedl
The Immune Response Modifier and Toll-Like Receptor 7 Agonist S-27609 Selectively Induces IL-12 and TNF-{alpha} Production in CD11c+CD11b+CD8- Dendritic Cells
J. Immunol., August 1, 2003; 171(3): 1156 - 1163.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
N. Setterblad, C. Roucard, C. Bocaccio, J.-P. Abastado, D. Charron, and N. Mooney
Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells
J. Leukoc. Biol., July 1, 2003; 74(1): 40 - 48.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Camporeale, A. Boni, G. Iezzi, E. Degl'Innocenti, M. Grioni, A. Mondino, and M. Bellone
Critical Impact of the Kinetics of Dendritic Cells Activation on the in Vivo Induction of Tumor-specific T Lymphocytes
Cancer Res., July 1, 2003; 63(13): 3688 - 3694.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Ghosh, C. Pal, M. Ray, S. Maitra, L. Mandal, and S. Bandyopadhyay
Dendritic Cell-Based Immunotherapy Combined with Antimony-Based Chemotherapy Cures Established Murine Visceral Leishmaniasis
J. Immunol., June 1, 2003; 170(11): 5625 - 5629.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Flynn and B. Stockinger
Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation
Blood, June 1, 2003; 101(11): 4472 - 4478.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. S. Yang and E. C. Lattime
Tumor-induced Interleukin 10 Suppresses the Ability of Splenic Dendritic Cells to Stimulate CD4 and CD8 T-Cell Responses
Cancer Res., May 1, 2003; 63(9): 2150 - 2157.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. J. Kobie, R. S. Wu, R. A. Kurt, S. Lou, M. K. Adelman, L. J. Whitesell, L. V. Ramanathapuram, C. L. Arteaga, and E. T. Akporiaye
Transforming Growth Factor {beta} Inhibits the Antigen-Presenting Functions and Antitumor Activity of Dendritic Cell Vaccines
Cancer Res., April 15, 2003; 63(8): 1860 - 1864.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
H.-R. Jiang, E. Muckersie, M. Robertson, and J. V. Forrester
Antigen-Specific Inhibition of Experimental Autoimmune Uveoretinitis by Bone Marrow-Derived Immature Dendritic Cells
Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1598 - 1607.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Soruri, Z. Kiafard, C. Dettmer, J. Riggert, J. Kohl, and J. Zwirner
IL-4 Down-Regulates Anaphylatoxin Receptors in Monocytes and Dendritic Cells and Impairs Anaphylatoxin-Induced Migration In Vivo
J. Immunol., March 15, 2003; 170(6): 3306 - 3314.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
B. A. Vorderstrasse, E. A. Dearstyne, and N. I. Kerkvliet
Influence of 2,3,7,8-Tetrachlorodibenzo-p-dioxin on the Antigen-Presenting Activity of Dendritic Cells
Toxicol. Sci., March 1, 2003; 72(1): 103 - 112.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Hou, Y. Wu, S. Sun, M. Shi, Y. Sun, C. Yang, G. Pei, Y. Gu, C. Zhong, and B. Sun
Pertussis Toxin Enhances Th1 Responses by Stimulation of Dendritic Cells
J. Immunol., February 15, 2003; 170(4): 1728 - 1736.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Abe, F. O. Yarovinsky, T. Murakami, A. N. Shakhov, A. V. Tumanov, D. Ito, L. N. Drutskaya, K. Pfeffer, D. V. Kuprash, K. L. Komschlies, et al.
Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo
Blood, February 15, 2003; 101(4): 1477 - 1483.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. J. Weigel, N. Nath, P. A. Taylor, A. Panoskaltsis-Mortari, W. Chen, A. M. Krieg, K. Brasel, and B. R. Blazar
Comparative analysis of murine marrow-derived dendritic cells generated by Flt3L or GM-CSF/IL-4 and matured with immune stimulatory agents on the in vivo induction of antileukemia responses
Blood, December 1, 2002; 100(12): 4169 - 4176.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Balmelli, S. Demotz, H. Acha-Orbea, P. De Grandi, and D. Nardelli-Haefliger
Trachea, Lung, and Tracheobronchial Lymph Nodes Are the Major Sites Where Antigen-Presenting Cells Are Detected after Nasal Vaccination of Mice with Human Papillomavirus Type 16 Virus-Like Particles
J. Virol., November 13, 2002; 76(24): 12596 - 12602.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
H.-R. Jiang, E. Muckersie, M. Robertson, H. Xu, J. Liversidge, and J. V. Forrester
Secretion of interleukin-10 or interleukin-12 by LPS-activated dendritic cells is critically dependent on time of stimulus relative to initiation of purified DC culture
J. Leukoc. Biol., November 1, 2002; 72(5): 978 - 985.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. D. de Gruijl, S. A. Luykx-de Bakker, B. W. Tillman, A. J. M. van den Eertwegh, J. Buter, S. M. Lougheed, G. J. van der Bij, A. M. Safer, H. J. Haisma, D. T. Curiel, et al.
Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors
J. Immunol., November 1, 2002; 169(9): 5322 - 5331.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. M. Lee, A. Mahtabifard, R. Yamada, R. G. Crystal, and R. J. Korst
Adenovirus Vector-mediated Overexpression of a Truncated Form of the p65 Nuclear Factor {kappa}B cDNA in Dendritic Cells Enhances Their Function Resulting in Immune-mediated Suppression of Preexisting Murine Tumors
Clin. Cancer Res., November 1, 2002; 8(11): 3561 - 3569.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. R. Arron, Y. Pewzner-Jung, M. C. Walsh, T. Kobayashi, and Y. Choi
Regulation of the Subcellular Localization of Tumor Necrosis Factor Receptor-associated Factor (TRAF)2 by TRAF1 Reveals Mechanisms of TRAF2 Signaling
J. Exp. Med., October 7, 2002; 196(7): 923 - 934.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. B. Lutz, M. Schnare, M. Menges, S. Rossner, M. Rollinghoff, G. Schuler, and A. Gessner
Differential Functions of IL-4 Receptor Types I and II for Dendritic Cell Maturation and IL-12 Production and Their Dependency on GM-CSF
J. Immunol., October 1, 2002; 169(7): 3574 - 3580.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Miller, V. G. Pillarisetty, A. B. Shah, S. Lahrs, Z. Xing, and R. P. DeMatteo
Endogenous Granulocyte-Macrophage Colony-Stimulating Factor Overexpression In Vivo Results in the Long-Term Recruitment of a Distinct Dendritic Cell Population with Enhanced Immunostimulatory Function
J. Immunol., September 15, 2002; 169(6): 2875 - 2885.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. N. Bykovskaia, G. V. Shurin, S. Graner, M. L. Bunker, W. Olson, R. Thomas, M. R. Shurin, S. Marks, W. J. Storkus, and J. Shogan
Differentiation of Immunostimulatory Stem-Cell- and Monocyte-Derived Dendritic Cells Involves Maturation of Intracellular Compartments Responsible for Antigen Presentation and Secretion
Stem Cells, September 1, 2002; 20(5): 380 - 393.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. J. O'Sullivan and R. Thomas
CD40 Ligation Conditions Dendritic Cell Antigen-Presenting Function Through Sustained Activation of NF-{kappa}B
J. Immunol., June 1, 2002; 168(11): 5491 - 5498.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Steptoe, J. M. Ritchie, and L. C. Harrison
Increased Generation of Dendritic Cells from Myeloid Progenitors in Autoimmune-Prone Nonobese Diabetic Mice
J. Immunol., May 15, 2002; 168(10): 5032 - 5041.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. K. Basak, A. Harui, M. Stolina, S. Sharma, K. Mitani, S. M. Dubinett, and M. D. Roth
Increased dendritic cell number and function following continuous in vivo infusion of granulocyte macrophage-colony-stimulating factor and interleukin-4
Blood, April 15, 2002; 99(8): 2869 - 2879.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Bachleitner-Hofmann, A. Stift, J. Friedl, R. Pfragner, K. Radelbauer, P. Dubsky, G. Schuller, T. Benko, B. Niederle, C. Brostjan, et al.
Stimulation of Autologous Antitumor T-Cell Responses Against Medullary Thyroid Carcinoma Using Tumor Lysate-Pulsed Dendritic Cells
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1098 - 1104.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Q. Khan, Y. Shen, Z.-Q. Wu, T. A. Wynn, and C. M. Snapper
Endogenous Pro- and Anti-Inflammatory Cytokines Differentially Regulate an In Vivo Humoral Response to Streptococcus pneumoniae
Infect. Immun., February 1, 2002; 70(2): 749 - 761.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. G. Pendl, C. Robert, M. Steinert, R. Thanos, R. Eytner, E. Borges, M. K. Wild, J. B. Lowe, R. C. Fuhlbrigge, T. S. Kupper, et al.
Immature mouse dendritic cells enter inflamed tissue, a process that requires E- and P-selectin, but not P-selectin glycoprotein ligand 1
Blood, February 1, 2002; 99(3): 946 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
T. Schuler, T. Kammertoens, S. Preiss, P. Debs, N. Noben-Trauth, and T. Blankenstein
Generation of Tumor-associated Cytotoxic T Lymphocytes Requires Interleukin 4 from CD8+ T Cells
J. Exp. Med., December 17, 2001; 194(12): 1767 - 1775.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
K. Kato, Y. Takaue, and H. Wakasugi
T-cell-conditioned medium efficiently induces the maturation and function of human dendritic cells
J. Leukoc. Biol., December 1, 2001; 70(6): 941 - 949.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. J. Kirk, D. Hartigan-O'Connor, and J. J. Mule
The Dynamics of the T-Cell Antitumor Response: Chemokine-secreting Dendritic Cells Can Prime Tumor-reactive T Cells Extranodally
Cancer Res., December 1, 2001; 61(24): 8794 - 8802.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Li, B. Schuler-Thurner, G. Schuler, C. Huber, and B. Seliger
Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation
Int. Immunol., December 1, 2001; 13(12): 1515 - 1523.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Okada, T. Saito, Y. Masunaga, Y. Tsukada, S. Nakagawa, H. Mizuguchi, K. Mori, Y. Okada, T. Fujita, T. Hayakawa, et al.
Efficient Antigen Gene Transduction Using Arg-Gly-Asp Fiber-Mutant Adenovirus Vectors Can Potentiate Antitumor Vaccine Efficacy and Maturation of Murine Dendritic Cells
Cancer Res., November 1, 2001; 61(21): 7913 - 7919.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Kotera, K. Shimizu, and J. J. Mule
Comparative Analysis of Necrotic and Apoptotic Tumor Cells As a Source of Antigen(s) in Dendritic Cell-based Immunization
Cancer Res., November 1, 2001; 61(22): 8105 - 8109.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
A. Mehling, K. Loser, G. Varga, D. Metze, T. A. Luger, T. Schwarz, S. Grabbe, and S. Beissert
Overexpression of CD40 Ligand in Murine Epidermis Results in Chronic Skin Inflammation and Systemic Autoimmunity
J. Exp. Med., August 27, 2001; 194(5): 615 - 628.
[Abstract] [Full Text] [PDF]


Home page